(a) General.
(1) Tolerances are established for residues of tepraloxydim, including its metabolites and degradates, in or on the commodities in the table below. Compliance with the tolerance levels specified below is to be determined by measuring only the combined residues of tepraloxydim, (2-[1-[[[(2E)-3-chloro-2-propen-1-yl]oxy]imino]propyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)-2-cyclohexen-1-one) and its metabolites convertible to GP (3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid) and OH-GP (3-hydroxy-3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid), calculated as tepraloxydim, in or on the commodities.
| Commodity | Parts per million |
Expiration/ revocation date |
|---|---|---|
| Cotton, undelinted seed | 0.2 | 12/31/18 |
| Cotton, gin byproducts | 3.0 | 12/31/18 |
| Flax, seed | 0.10 | 12/31/18 |
| Grain, aspirated fraction | 1200.0 | 12/31/18 |
| Pea and bean, dried shelled, except soybean, subgroup 6C1 | 0.10 | 12/31/18 |
| Soybean, seed | 6.0 | 12/31/18 |
| Soybean, hulls | 8.0 | 12/31/18 |
| Sunflower subgroup 20B1 | 0.20 | 12/31/18 |
(2) Tolerances are established for residues of tepraloxydim, including its metabolites and degradates, in or on the commodities in the table below. Compliance with the tolerance levels specified below is to be determined by measuring only the combined residues of tepraloxydim (2-[1-[[[(2E)-3-chloro-2-propen-1-yl]oxy]imino]propyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)-2-cyclohexen-1-one) and its metabolites convertible to GP (3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid), OH-GP (3-hydroxy-3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid), and GL (3-(2-oxotetrahydropyran-4-yl)-1,5-dioic acid), calculated as tepraloxydim, in or on the commodities.
| Commodity | Parts per million |
Expiration/ revocation date |
|---|---|---|
| Cattle, fat | 0.15 | 12/31/18 |
| Cattle, kidney | 0.50 | 12/31/18 |
| Cattle, meat | 0.20 | 12/31/18 |
| Cattle, meat byproducts, except kidney | 0.20 | 12/31/18 |
| Egg | 0.20 | 12/31/18 |
| Goat, fat | 0.15 | 12/31/18 |
| Goat, kidney | 0.50 | 12/31/18 |
| Goat, meat | 0.20 | 12/31/18 |
| Goat, meat byproducts, except kidney | 0.20 | 12/31/18 |
| Hog, fat | 0.15 | 12/31/18 |
| Hog, kidney | 0.50 | 12/31/18 |
| Hog, meat | 0.20 | 12/31/18 |
| Hog, meat byproducts, except kidney | 0.20 | 12/31/18 |
| Horse, fat | 0.15 | 12/31/18 |
| Horse, kidney | 0.50 | 12/31/18 |
| Horse, meat | 0.20 | 12/31/18 |
| Horse, meat byproducts, except kidney | 0.20 | 12/31/18 |
| Milk | 0.10 | 12/31/18 |
| Poultry, fat | 0.30 | 12/31/18 |
| Poultry, liver | 1.00 | 12/31/18 |
| Poultry, meat | 0.20 | 12/31/18 |
| Poultry, meat byproducts, except liver | 0.20 | 12/31/18 |
| Sheep, fat | 0.15 | 12/31/18 |
| Sheep, kidney | 0.50 | 12/31/18 |
| Sheep, meat | 0.20 | 12/31/18 |
| Sheep, meat byproducts, except kidney | 0.20 | 12/31/18 |
(b) Section 18 emergency exemptions. [Reserved]
(c) Tolerances with regional registrations. A tolerance with regional registration, as defined in § 180.1(l), is established for residues of tepraloxydim, including its metabolites and degradates, in or on the commodities in the table below. Compliance with the tolerance levels specified below is to be determined by measuring only the combined residues of tepraloxydim (2-[1-[[[(2E)-3-chloro-2-propen-1-yl]oxy]imino]propyl]-3-hydroxy-5-(tetrahydro-2H-pyran-4-yl)-2-cyclohexen-1-one) and its metabolites convertible to GP (3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid) and OH-GP (3-hydroxy-3-(tetrahydropyran-4-yl)pentane-1,5-dioic acid), calculated as tepraloxydim, in or on the commodities.
| Commodity | Parts per million |
Expiration/ revocation date |
|---|---|---|
| Canola, seed | 0.50 | 12/31/18 |
(d) Indirect or inadvertent residues. [Reserved]
[66 FR 40150, Aug. 2, 2001, as amended at 72 FR 54588, Sept. 26, 2007; 76 FR 34885, June 15, 2011; 76 FR 82152, Dec. 30, 2011; 81 FR 34906, June 1, 2016]